Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. On August 5, blood-testing startup Sight Diagnostics raised another ...
Sysmex America, a subsidiary of Sysmex Corporation (OTC: SSMXY), received FDA clearance yesterday for a complete blood cell count (CBC) test that can be run in more health care settings, including ...
CHICAGO, March 3, 2025 /PRNewswire/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, today ...
YOKNEAM ILLIT, Israel, Nov. 16, 2022 /PRNewswire/ -- A study published in eJHaem Journal of Hematology in August 2022, compared PixCell Medical's FDA-cleared Point-of-Care 5-part differential CBC ...
Once COVID-19 patients enter hospitals, are workers who test patients’ blood at risk of becoming infected? One common test that physicians use to monitor patients is the complete blood count (CBC) — ...